Completed PHASE3 INTERVENTIONAL 2-arm NCT01019642

Vitamin D, C-reactive Protein and Insulin Resistance

Effect of Vitamin D Supplementation on C-reactive Protein and Insulin Resistance in Postmenopausal Women With Type 2 Diabetes Mellitus

Sponsor: Ellison Medical / International Nutrition Foundation

Conditions Diabetes Insulin Resistance Low-intensity Chronic Inflammation

Interventions cholecalciferol placebo

Updated 4 times since 2017 Last updated: Nov 23, 2009 Started: Mar 31, 2008 Primary completion: Oct 31, 2008 Completion: Oct 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01019642, this PHASE3 trial focuses on Diabetes and Insulin Resistance and remains completed. Sponsored by Ellison Medical / International Nutrition Foundation, it has been updated 4 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2017 — Jan 2021 [monthly]

Completed PHASE3

First recorded

Mar 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ellison Medical / International Nutrition Foundation
Instituto Mexicano del Seguro Social
Instituto Nacional de Salud Publica, Mexico
Tufts University

Data source: Instituto Nacional de Salud Publica, Mexico

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cuernavaca, Mexico